MitoRx Therapeutics

Oxford, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of small molecule therapeutics designed for weight loss with muscle preservation in obesity-related and cardiometabolic conditions. MitoRx Therapeutics is based in Oxford, United Kingdom and was founded in 2021. Its last reported valuation was $31.4 million in Nov 2025. It has raised $17.5 million.

Last reported valuation

$31.4M

Oct 2026

Priced at

—

Total raised

$17.5M

Last round

—

How much has MitoRx Therapeutics raised?

$17.5Macross 0 recorded rounds

Free account

More of MitoRx Therapeutics with a free account

·The complete investor list: 13 names
·Watch MitoRx Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

MitoRx Therapeutics investors

13 investors are on record for MitoRx Therapeutics, including Future Planet Capital, UK Innovation & Science Seed Fund, WCS Nominees and Empirical Ventures.

For fundraisers

Raising for a company like MitoRx Therapeutics?

13 investors have backed MitoRx Therapeutics.

See all 13 investors →

Frequently asked about MitoRx Therapeutics

How much has MitoRx Therapeutics raised?: MitoRx Therapeutics has raised $17.5M in total across 0 recorded funding rounds.